GISAID's Role in Pandemic Response
China CDC Wkly
.
2021 Dec 3;3(49):1049-1051.
doi: 10.46234/ccdcw2021.255.
Authors
Shruti Khare
1
2
,
Céline Gurry
1
,
Lucas Freitas
1
3
,
Mark B Schultz
1
,
Gunter Bach
1
,
Amadou Diallo
1
4
,
Nancy Akite
1
,
Joses Ho
1
2
,
Raphael Tc Lee
1
2
,
Winston Yeo
1
2
,
Gisaid Core Curation Team
1
2
3
5
6
7
8
,
Sebastian Maurer-Stroh
1
2
9
10
11
Affiliations
1
GISAID Global Data Science Initiative (GISAID), Munich, Germany.
2
Bioinformatics Institute, Agency for Science Technology and Research, Singapore.
3
Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.
4
Institut Pasteur de Dakar, Dakar, Senegal.
5
National Institutes of Biotechnology Malaysia, Selangor, Malaysia.
6
Smorodintsev Research Institute of Influenza, St. Petersburg, Russia.
7
Genome Institute of Singapore, Agency for Science Technology and Research, Singapore.
8
China National GeneBank, Shenzhen, China.
9
ASTAR Infectious Disease Labs (ID Labs), Singapore.
10
National Public Health Laboratory, National Centre for Infectious Diseases, Ministry of Health, Singapore.
11
Department of Biological Sciences, National University of Singapore, Singapore.
PMID:
34934514
PMCID:
PMC8668406
DOI:
10.46234/ccdcw2021.255
No abstract available
Keywords:
COVID-19; Coronavirus; Data sharing; GISAID.